Abstract:AIMS This double-blind, placebo-controlled trial was designed to evaluate the pharmacodynamics, pharmacokinetics, safety, and tolerability of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y(12) ADP receptor antagonist compared with clopidogrel, during multiple oral dosing in healthy subjects. METHODS Thirty subjects received placebo, prasugrel 5 mg, 10 mg, or 20 mg, or clopidogrel 75 mg orally, daily for 10 days. Platelet aggregation, bleeding time, and prasugrel metabolites were measured and adverse events were recorded. RESULTS Inhibition of ADP-induced platelet aggregation reached steady state by day 3 following prasugrel 10 and 20 mg compared with 5 days for clopidogrel 75 mg or prasugrel 5 mg. Compared with placebo, at 24 h after the last dose of study drug, inhibition of platelet aggregation using (20 microm) ADP was significantly higher in the prasugrel 10 mg group (58.2 +/- 4.9% vs. 9.2 +/- 4.0%, P < 0.001) with no difference in the clopidogrel group (15.7 +/- 6.8% vs. 9.2 +/- 4.0%, P = 0.78). With 5 microm ADP, inhibition of platelet aggregation with prasugrel 10 mg and clopidogrel 75 mg was significantly higher than with placebo (prasugrel 10 mg, 70.5 +/- 4.7%; clopidogrel 75 mg, 36.5 +/- 9.0%; vs. placebo, 11.3 +/- 5.1%; P < 0.0001 and P = 0.02). On day 10 at 4 h postdose, bleeding time was prolonged with prasugrel 10 mg (prasugrel 10 mg, 706 +/- 252 s vs. placebo, 221 +/- 38 s, P = 0.05) but not with clopidogrel (283 +/- 56 s, P = 0.98). There were no clinically significant bleeding events, serious adverse events, or discontinuations of the study drug. CONCLUSIONS Compared with clopidogrel 75 mg, prasugrel 10 mg and 20 mg daily for 10 days resulted in more rapid, more consistent, and higher levels of platelet inhibition.

Nanosecond Pulse Generation in Lumped Normally Dispersive All-Fiber Mode-Locked Laser

Stable Nanosecond-Pulse Fiber Lasers Mode-Locked with Molybdenum Diselenide

Femtosecond Mode-locked Fiber Laser at 1 Μm Via Optical Microfiber Dispersion Management

Chemical and physical studies of cyclitols containing four or five hydroxyl groups.

Mode-locked ytterbium fiber lasers using a large modulation depth carbon nanotube saturable absorber without an additional spectral filter

Above 100 Nj All-Normal-dispersion Femtosecond Pulse Generation from a Large-Core Multi-Mode Fiber Laser

The generation and observation of pulses with switchable single/dual wavelengths and tunable bandwidth from a SWNT mode-locked Er-doped fiber laser

Sub-100fs Pulse Generation from a Fiber Oscillator Mode-Locked by Nanotubes

Generation of Ultra‐fast Laser Pulses Using Nanotube Mode‐lockers

Large Anomalous-Dispersion Mode-Locked Fiber Laser Based on a Chirped Fiber Bragg Grating Pair

Sub-10 ns mode-locked fiber lasers with multimode fiber saturable absorber

Pulse Dynamics in Carbon Nanotube Mode-Locked Fiber Lasers Near Zero Cavity Dispersion

Stable Mode-Locked Nanosecond Chirp-Free Pulse Generation with Ultra-Narrow Bandwidth

Low-Repetition-Rate All-Fiber All-Normal-Dispersion Yb-Doped Mode-Locked Fiber Laser

783-MHz fundamental repetition rate all-fiber ring laser mode-locked by carbon nanotubes

Spatiotemporal nonlinear dynamics in multimode fiber laser based on carbon nanotubes

A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans.

Double-Wall Carbon Nanotubes for Wide-Band, Ultrafast Pulse Generation

Yb-doped all fiber picosecond laser based on grade-index multimode fiber with microcavity

Ultrafast Erbium-doped Fiber Laser Mode-locked by a Carbon Nanotube Saturable Absorber